Financials SMAIO

Stocks

Market Closed - Euronext Paris 11:55:00 2026-09-04 EDT			5-day change	1st Jan Change
7.660 ^EUR	+1.32%		+1.32%	+22.56%

07-16	SMAIO Reports Group Sales Results for the Second Quarter and First Half Ended June 30, 2026	CI
07-16	SMAIO Continued Expansion of the Network in the United States, with 5 New Centers Added to the Network and 13 New Surgeons Who Have Performed Their First Implants	CI

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Net sales ¹	2.1	2.4	5.383	5.498	9.2	11	16	20.9
Change	-	14.29%	124.29%	2.14%	67.33%	19.57%	45.45%	30.62%
EBITDA ¹	-	-2.544	2.059	-1.751	-1.22	-1.1	1.45	2.55
Change	-	-	180.93%	-185.03%	30.32%	9.83%	231.82%	75.86%
EBIT ¹	-	-4	0.7368	-3.184	-2.628	-2.6	-0.15	0.8
Change	-	-	118.42%	-532.13%	17.47%	1.06%	94.23%	633.33%
Interest Paid ¹	-	-0.0186	-0.2211	0.0925	-	-0.152	-0.137	-0.1105
Earnings before Tax (EBT) ¹	-	-	-	-	-	-2.6	-0.2	0.5
Change	-	-	-	-	-	-	92.31%	350%
Net income ¹	-3.1	2.846	1.058	-2.349	-2.229	-2.25	0.25	1.2
Change	-	191.8%	-62.8%	-321.91%	5.11%	-0.95%	111.11%	380%
Announcement Date	4/29/22	4/11/23	4/29/24	4/24/25	4/27/26	-	-	-

¹EUR in Million

Estimates

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Net Debt ¹	-	-5.04	-3.7	-0.92	-0.99	-1.5	-0.9	-0.2
Change	-	-	26.59%	75.14%	-7.61%	-51.94%	40%	77.78%
Announcement Date	4/29/22	4/11/23	4/29/24	4/24/25	4/27/26	-	-	-

¹EUR in Million

Estimates

Fiscal Period: December	2022	2023	2024	2025	2026	2027	2028
CAPEX ¹	0.8303	1.155	1.554	1.558	1.5	1.55	1.6
Change	-	39.09%	34.56%	0.29%	-3.75%	3.33%	3.23%
Free Cash Flow (FCF) ¹	5.106	-1.354	-2.99	-1.295	-2.75	-1.25	-0.1
Change	-	-126.52%	-120.79%	56.7%	-112.42%	54.55%	92%
Announcement Date	4/11/23	4/29/24	4/24/25	4/27/26	-	-	-

¹EUR in Million

Estimates

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Profitability
EBITDA Margin (%)	-	-106.01%	38.25%	-31.84%	-13.26%	-10%	9.06%	12.2%
EBIT Margin (%)	-	-166.67%	13.69%	-57.91%	-28.56%	-23.64%	-0.94%	3.83%
EBT Margin (%)	-	-	-	-	-	-23.64%	-1.25%	2.39%
Net margin (%)	-147.62%	118.57%	19.66%	-42.72%	-24.23%	-20.45%	1.56%	5.74%
FCF margin (%)	-	212.73%	-25.15%	-54.38%	-14.07%	-25%	-7.81%	-0.48%
FCF / Net Income (%)	-	179.42%	-127.93%	127.28%	58.08%	122.22%	-500%	-8.33%
Profitability
ROA	-	-	-	-	-	-	2.35%	9.35%
ROE	-	29.2%	-	-	-	-	2.65%	11.25%
Financial Health
Leverage (Debt/EBITDA)	-	-	-	-	-	-	-	-
Debt / Free cash flow	-	-	-	-	-	-	-	-
Capital Intensity
CAPEX / Current Assets (%)	-	34.59%	21.45%	28.26%	16.94%	13.64%	9.69%	7.66%
CAPEX / EBITDA (%)	-	-32.63%	56.09%	-88.77%	-127.75%	-136.36%	106.9%	62.75%
CAPEX / FCF (%)	-	16.26%	-85.29%	-51.98%	-120.38%	-54.55%	-124%	-1,600%
Items per share
Cash flow per share ¹	-	-	-	-	-	-0.2	0.1	0.2
Change	-	-	-	-	-	-	150%	100%
Dividend per Share ¹	-	-	-	-	-	-	-	-
Change	-	-	-	-	-	-	-	-
Book Value Per Share ¹	-	-	-	-	-	1.1	1.1	1.3
Change	-	-	-	-	-	-	0%	18.18%
EPS ¹	-	-	0.2024	-0.45	-0.41	-0.39	0.04	0.215
Change	-	-	-	-322.33%	8.89%	4.88%	110.26%	437.5%
Nbr of stocks (in thousands)	-	-	5,229	5,216	5,639	5,633	5,633	5,633
Announcement Date	-	-	4/29/24	4/24/25	4/27/26	-	-	-